Function through Synthesis-Informed Design

Accounts of Chemical Research

Volumn 48, Issue 3, 2015, Pages 752-760

  Wender, Paul A ^a   Quiroz, Ryan V ^a   Stevens, Matthew C ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; BRYOSTATIN; LIGAND; ORGANIC COMPOUND; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DNA CLEAVAGE; DRUG DELIVERY SYSTEM; DRUG DESIGN; HUMAN; METABOLISM; SYNTHESIS;

ANIMALS; BIOLOGICAL PRODUCTS; BRYOSTATINS; DNA CLEAVAGE; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; LIGANDS; ORGANIC CHEMICALS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS;

EID: 84925446149     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/acs.accounts.5b00004     Document Type: Article

References (49)

1. Cohen, P. S.; Cohen, S. M. Wöhler's Synthesis of Urea: How Do the Textbooks Report It? J. Chem. Educ. 1996, 73, 883-886
2. Wender, P. A.; Miller, B. L. Synthesis at the Molecular Frontier Nature 2009, 460, 197-201
3. Wender, P. A. Introduction: Frontiers in Organic Synthesis Chem. Rev. 1996, 96, 1-2 and other articles in the special issue.
4. Wender, P. A.; Verma, V. A.; Paxton, T. J.; Pillow, T. H. Function-Oriented Synthesis, Step Economy, and Drug Design Acc. Chem. Res. 2007, 41, 40-49
5. Wender, P. A. Toward the Ideal Synthesis and Molecular Function through Synthesis-Informed Design Nat. Prod. Rep. 2014, 31, 433-440
6. Cragg, G. M.; Grothaus, P. G.; Newman, D. J. Impact of Natural Products on Developing New Anti-Cancer Agents Chem. Rev. 2009, 109, 3012-3043
7. Cragg, G. M.; Grothaus, P. G.; Newman, D. J. New Horizons for Old Drugs and Drug Leads J. Nat. Prod. 2014, 77, 703-723
8. Konaklieva, M. I. Molecular Targets of β-Lactam-Based Antimicrobials: Beyond the Usual Suspects Antibiotics 2014, 3, 128-142
9. Ruddigkeit, L.; van Deursen, R.; Blum, L. C.; Reymond, J.-L. Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17 J. Chem. Inf. Model. 2012, 52, 2864-2875
10. Awale, M.; Reymond, J.-L. Atom Pair 2D-Fingerprints Perceive 3D-Molecular Shape and Pharmacophores for Very Fast Virtual Screening of ZINC and GDB-17 J. Chem. Inf. Model. 2014, 54, 1892-1907
11. Seebach, D. Organic Synthesis-Where Now? Angew. Chem., Int. Ed. Engl. 1990, 29, 1320-1367
12. Sheldon, R. Introduction to Green Chemistry, Organic Synthesis and Pharmaceuticals. In Green Chemistry in the Pharmaceutical Industry; Dunn, P. J.; Wells, A. S.; Williams, M. T., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2010; pp 1-20.
13. Trost, B. M. The Atom Economy - a Search for Synthetic Efficiency Science 1991, 254, 1471-1477
14. Bryan, M. C.; Dillon, B.; Hamann, L. G.; Hughes, G. J.; Kopach, M. E.; Peterson, E. A.; Pourashraf, M.; Raheem, I.; Richardson, P.; Richter, D.; Sneddon, H. F. Sustainable Practices in Medicinal Chemistry: Current State and Future Directions J. Med. Chem. 2013, 56, 6007-6021
15. Wender, P. A.; Koehler, K. F.; Sharkey, N. A.; Dell'Aquila, M. L.; Blumberg, P. M. Analysis of the Phorbol Ester Pharmacophore on Protein Kinase C as a Guide to the Rational Design of New Classes of Analogs Proc. Natl. Acad. Sci. U. S. A. 1986, 83, 4214-4218
16. Hecker, E. In Carcinogenesis-A Comprehensive Survey; Slaga, T. J.; Sivak, A.; Boutwell, R. K., Eds.; Raven Press: New York, 1978; Vol. 2, p 11.
17. Steinberg, S. F. Structural Basis of Protein Kinase C Isoform Function Physiol. Rev. 2008, 88, 1341-1378
18. Newton, A. C. Protein Kinase C: Poised to Signal Am. J. Physiol.: Endocrinol. Metab. 2010, 298, E395-E402
19. Wender, P. A.; Rice, K. D.; Schnute, M. E. The First Formal Asymmetric Synthesis of Phorbol J. Am. Chem. Soc. 1997, 119, 7897-7898 and references cited therein.
20. Hawkins, P. C. D.; Skillman, A. G.; Warren, G. L.; Ellingson, B. A.; Stahl, M. T. OMEGA 2.5.1.4: OpenEye Scientific Software, Santa Fe, NM, http://www.eyesopen.com.
21. Molecular structures visualized using OpenEye VIDA software.
22. Wender, P. A.; Loy, B. A.; Schrier, A. J. Translating Nature's Library: The Bryostatins and Function-Oriented Synthesis Isr. J. Chem. 2011, 51, 453-472
23. Pettit, G. R.; Herald, C. L.; Doubek, D. L.; Herald, D. L.; Arnold, E.; Clardy, J. Isolation and Structure of Bryostatin 1 J. Am. Chem. Soc. 1982, 104, 6846-6848
24. DeChristopher, B. A.; Fan, A. C.; Felsher, D. W.; Wender, P. A. "Picolog," a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced Lymphoma In Vivo Oncotarget 2012, 3, 58-66
25. Barr, P. M.; Lazarus, H. M.; Cooper, B. W.; Schluchter, M. D.; Panneerselvam, A.; Jacobberger, J. W.; Hsu, J. W.; Janakiraman, N.; Simic, A.; Dowlati, A.; Remick, S. C. Phase II Study of Bryostatin 1 and Vincristine for Aggressive Non-Hodgkin Lymphoma Relapsing after an Autologous Stem Cell Transplant Am. J. Hematol. 2009, 84, 484-487
26. Khan, T. K.; Nelson, T. J.; Verma, V. A.; Wender, P. A.; Alkon, D. L. A Cellular Model of Alzheimer's Disease Therapeutic Efficacy: PKC Activation Reverses Abeta-Induced Biomarker Abnormality on Cultured Fibroblasts Neurobiol. Dis. 2009, 34, 332-339
27. Wender, P. A.; Kee, J.-M.; Warrington, J. M. Practical Synthesis of Prostratin, DPP, and Their Analogs, Adjuvant Leads Against Latent HIV Science 2008, 320, 649-652
28. Bullen, C. K.; Laird, G. M.; Durand, C. M.; Siliciano, J. D.; Siliciano, R. F. New Ex Vivo Approaches Distinguish Effective and Ineffective Single Agents for Reversing HIV-1 Latency in Vivo Nat. Med. 2014, 20, 425-429
29. Wender, P. A.; Cribbs, C. M.; Koehler, K. F.; Sharkey, N. A.; Herald, C. L.; Kamano, Y.; Pettit, G. R.; Blumberg, P. M. Modeling of the Bryostatins to the Phorbol Ester Pharmacophore on Protein Kinase C Proc. Natl. Acad. Sci. U. S. A. 1988, 85, 7197-7201
30. Wender, P. A.; Donnelly, A. C.; Loy, B. A.; Near, K. E.; Staveness, D. Rethinking the Role of Natural Products: Function-Oriented Synthesis, Bryostatin and Bryologs. In Natural Products in Medicinal Chemistry; Hanessian, S., Ed.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2014; Chapter 14, pp 475-544.
31. Wender, P. A.; Nakagawa, Y.; Near, K. E.; Staveness, D. Computer-Guided Design, Synthesis, and Protein Kinase C Affinity of a New Salicylate-Based Class of Bryostatin Analogs Org. Lett. 2014, 16, 5136-5139
32. Wender, P. A.; Staveness, D. Improved Protein Kinase C Affinity through Final Step Diversification of Simplified Salicylate-Derived Bryostatin Analog Scaffold Org. Lett. 2014, 16, 5140-5143
33. Wender, P. A.; Cribbs, C. M. Computer Assisted Molecular Design Related to the Protein Kinase C Receptor. In Advances in Medicinal Chemistry; Maryanoff, C. A.; Maryanoff, B. E., Eds.; JAI: Greenwich, CT, 1992; Vol. 1, pp 1-53.
34. Kikumori, M.; Yanagita, R. C.; Tokuda, H.; Suzuki, N.; Nagai, H.; Suenaga, K.; Irie, K. Structure-Activity Studies on the Spiroketal Moiety of a Simplified Analogue of Debromoaplysiatoxin with Antiproliferative Activity J. Med. Chem. 2012, 55, 5614-5626
35. Karaman, M. W.; Herrgard, S.; Treiber, D. K.; Gallant, P.; Atteridge, C. E.; Campbell, B. T.; Chan, K. W.; Ciceri, P.; Davis, M. I.; Edeen, P. T.; Faraoni, R.; Floyd, M.; Hunt, J. P.; Lockhart, D. J.; Milanov, Z. V.; Morrison, M. J.; Pallares, G.; Patel, H. K.; Pritchard, S.; Wodicka, L. M.; Zarrinkar, P. P. A Quantitative Analysis of Kinase Inhibitor Selectivity Nat. Biotechnol. 2008, 26, 127-132
36. Wender, P. A.; Axtman, A. D.; Golden, J. E.; Kee, J.-M.; Sirois, L. E.; Quiroz, R. V.; Stevens, M. C. Function through Bio-Inspired, Synthesis-Informed Design: Step-Economical Syntheses of Designed Kinase Inhibitors Org. Chem. Front. 2014, 1, 1166-1171
37. Gani, O. A. B. S. M.; Engh, R. A. Protein Kinase Inhibition of Clinically Important Staurosporine Analogues Nat. Prod. Rep. 2010, 27, 489-498
38. Wender, P. A.; Fournogerakis, D. N.; Jeffreys, M. S.; Quiroz, R. V.; Inagaki, F.; Pfaffenbach, M. Structural Complexity Through Multicomponent Cycloaddition Cascades Enabled by Dual-Purpose, Reactivity Regenerating 1,2,3-Triene Equivalents Nat. Chem. 2014, 6, 448-452 and references therein.
39. Bergman, R. G. Reactive 1,4-dehydroaromatics Acc. Chem. Res. 1973, 6, 25-31
40. Konishi, M.; Ohkuma, H.; Tsuno, T.; Oki, T.; VanDuyne, G. D.; Clardy, J. Crystal and Molecular Structure of Dynemicin A: A Novel 1,5-diyn-3-ene Antitumor Antibiotic J. Am. Chem. Soc. 1990, 112, 3715-3716
41. Wender, P. A.; Zercher, C. K. Studies on DNA-cleaving Agents: Synthesis of a Functional Dynemicin Analogue J. Am. Chem. Soc. 1991, 113, 2311-2313
42. Wender, P. A.; Beckham, S.; O'Leary, J. G. A Second Generation Photochemically Activatable Dynemicin Analog: A Concise Synthesis and DNA Cleavage Studies Synthesis 1994, 1994, 1278-1282 and references therein.
43. Wender, P. A.; Touami, S. M.; Alayrac, C.; Philipp, U. C. Triazole Photonucleases: A New Family of Light Activatable DNA Cleaving Agents J. Am. Chem. Soc. 1996, 118, 6522-6523
44. Touami, S. M.; Poon, C. C.; Wender, P. A. Sequence Specific DNA Cleavage by Conjugates of Benzotriazoles and Minor Groove Binders J. Am. Chem. Soc. 1997, 119, 7611-7612
45. Stanzl, E. G.; Trantow, B. M.; Vargas, J. R.; Wender, P. A. Fifteen Years of Cell-Penetrating, Guanidinium-Rich Molecular Transporters: Basic Science, Research Tools, and Clinical Applications Acc. Chem. Res. 2013, 46, 2944-2954
46. Wender, P. A.; Mitchell, D. J.; Pattabiraman, K.; Pelkey, E. T.; Steinman, L.; Rothbard, J. B. The Design, Synthesis, and Evaluation of Molecules That Enable or Enhance Cellular Uptake: Peptoid Molecular Transporters Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 13003-13008
47. Rothbard, J. B.; Jessop, T. C.; Lewis, R. S.; Murray, B. A.; Wender, P. A. Role of Membrane Potential and Hydrogen Bonding in the Mechanism of Translocation of Guanidinium-Rich Peptides into Cells J. Am. Chem. Soc. 2004, 126, 9506-9507
48. Wender, P. A.; Galliher, W. C.; Goun, E. A.; Jones, L. R.; Pillow, T. H. The Design of Guanidinium-rich Transporters and Their Internalization Mechanisms Adv. Drug Delivery Rev. 2008, 60, 452-472
49. Geihe, E. I.; Cooley, C. B.; Simon, J. R.; Kiesewetter, M. K.; Edward, J. A.; Hickerson, R. P.; Kaspar, R. L.; Hedrick, J. L.; Waymouth, R. M.; Wender, P. A. Designed Guanidinium-rich Amphipathic Oligocarbonate Molecular Transporters Complex, Deliver and Release siRNA in Cells Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 13171-13176 and references therein.